RELT promotes the growth of esophageal squamous cell carcinoma by activating the NF-κB pathway.

Cell Cycle
Wenjian YaoLi Wei

Abstract

The members of the tumor necrosis factor receptor (TNFR) family have been demonstrated to play critical roles in various cancers. However, little is known about the function of the Receptor Expressed in Lymphoid Tissues (RELT) in cancers, which is a member of the TNFR family, especially in the esophageal squamous cell carcinoma (ESCC). In this study, we found that RELT expression was increased in ESCC tissues and was consequently associated with poor overall survival of ESCC patients. Moreover, RELT overexpression was found to promote cell growth, cell cycle progression, and suppressed cell apoptosis in vitro; it also decreased the expression of p27 and caspase 3, and increased the expression of survivin. In addition, RELT contributed to the tumorigenesis of ESCC in vivo. Furthermore, we suggest that RELT may function in the pathogenesis of ESCC by activating the nuclear factor κB (NF-κB) pathway. An inhibitor of NF-κB reversed the RELT-induced malignancy in the ESCC cells. Altogether, our findings identified that RELT served as an oncogene in ESCC through the NF-κB pathway, suggesting that RELT may be developed as a novel biomarker for the diagnosis and treatment of the ESCC.

References

Feb 14, 2002·Trends in Biochemical Sciences·Jean-Luc BodmerJürg Tschopp
Sep 2, 2003·Nature Reviews. Immunology·Bharat B Aggarwal
Jun 1, 2005·Trends in Immunology·Qiutang LiInder M Verma
Jan 4, 2006·Biochemical and Biophysical Research Communications·John K CusickHong-Bing Shu
Mar 15, 2006·Biochemical and Biophysical Research Communications·Tara C PolekTaly Spivak-Kroizman
Apr 29, 2008·Current Opinion in Genetics & Development·Willscott E Naugler, Michael Karin
May 8, 2008·Breast Cancer Research : BCR·Li ZhongKemp H Kernstine
Jul 21, 2011·Nature Immunology·Yinon Ben-Neriah, Michael Karin
Jan 20, 2012·Nature Reviews. Cancer·Neil D Perkins
Mar 23, 2012·Immunological Reviews·Joseph A DiDonatoMichael Karin
Jan 22, 2013·Nature Reviews. Drug Discovery·Michael CroftCarl F Ware
Feb 5, 2013·Lancet·Arjun PennathurJames D Luketich
May 3, 2014·Methods in Molecular Biology·Zhenzhen Wu, Leslie A Bruggeman
Sep 16, 2014·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayFreddie Bray

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft
flow cytometry
transfection
electrophoresis
PCR

Software Mentioned

GSEA
ImageJ
R
RELT

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Biochemical and Biophysical Research Communications
Pachai MouaJohn K Cusick
Transplant International : Official Journal of the European Society for Organ Transplantation
Christophe BourdeauxRaymond Reding
© 2021 Meta ULC. All rights reserved